----
Current ValuationThe current P/E ratio is 32.49, below the reasonable range, cheaper than 98.85% of the time in the past 1 years, and the industry ranks 28/52, the industry Median 6.58.
32.49xP/E
HK$50.65Stock price
HK$1.56Earnings per share
32.49xP/E
Stock priceHK$50.65Earnings per shareHK$1.56
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 48.03x
- Typical range
- 37.93x–57.53x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.58x
09182736
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.58x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
01276HKHENGRUI PHARMA | 32.49x | 20.10% | HK$336.17B |
01177HKSBP GROUP | 32.94x | 111.35% | HK$90.61B |
06996HKANTENGENE-B | 31.33x | 246.19% | HK$1.93B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
